176 related articles for article (PubMed ID: 38770543)
1. Alterations in regulators of the renal-bone axis, inflammation and iron status in older people with early renal impairment and the effect of vitamin D supplementation.
Christodoulou M; Aspray TJ; Piec I; Fraser WD; Schoenmakers I;
Age Ageing; 2024 May; 53(5):. PubMed ID: 38770543
[TBL] [Abstract][Full Text] [Related]
2. Early renal impairment affects hormonal regulators of calcium and bone metabolism and Wnt signalling and the response to vitamin D supplementation in healthy older adults.
Christodoulou M; Aspray TJ; Piec I; Washbourne C; Tang JCY; Fraser WD; Schoenmakers I;
J Steroid Biochem Mol Biol; 2023 May; 229():106267. PubMed ID: 36739953
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
[TBL] [Abstract][Full Text] [Related]
4. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
[TBL] [Abstract][Full Text] [Related]
5. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J
Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
[TBL] [Abstract][Full Text] [Related]
6. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
[TBL] [Abstract][Full Text] [Related]
7. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
Emrich IE; Brandenburg V; Sellier AB; Schauerte J; Wiedenroth J; Untersteller K; Lennartz CS; Seiler-Mussler S; Wagenpfeil S; Fliser D; Heine GH
Am J Nephrol; 2019; 49(3):203-211. PubMed ID: 30808827
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Supplementation for 12 Months in Older Adults Alters Regulators of Bone Metabolism but Does Not Change Wnt Signaling Pathway Markers.
Christodoulou M; Aspray TJ; Piec I; Washbourne C; Tang JC; Fraser WD; Schoenmakers I;
JBMR Plus; 2022 May; 6(5):e10619. PubMed ID: 35509637
[TBL] [Abstract][Full Text] [Related]
10. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients.
Yamashita K; Mizuiri S; Nishizawa Y; Kenichiro S; Doi S; Masaki T
Nephrology (Carlton); 2017 Dec; 22(12):947-953. PubMed ID: 27558654
[TBL] [Abstract][Full Text] [Related]
11. Phosphate control in reducing FGF23 levels in hemodialysis patients.
Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
[TBL] [Abstract][Full Text] [Related]
12. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.
Lerch C; Shroff R; Wan M; Rees L; Aitkenhead H; Kaplan Bulut I; Thurn D; Karabay Bayazit A; Niemirska A; Canpolat N; Duzova A; Azukaitis K; Yilmaz E; Yalcinkaya F; Harambat J; Kiyak A; Alpay H; Habbig S; Zaloszyc A; Soylemezoglu O; Candan C; Rosales A; Melk A; Querfeld U; Leifheit-Nestler M; Sander A; Schaefer F; Haffner D; ;
Nephrol Dial Transplant; 2018 Dec; 33(12):2208-2217. PubMed ID: 29481636
[TBL] [Abstract][Full Text] [Related]
13. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
[TBL] [Abstract][Full Text] [Related]
14. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
Bożentowicz-Wikarek M; Kocełak P; Owczarek A; Olszanecka-Glinianowicz M; Mossakowska M; Skalska A; Więcek A; Chudek J
Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Intravenous Iron, Inflammation and FGF23 in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5.
Muras-Szwedziak K; Nowicki M
Kidney Blood Press Res; 2018; 43(1):143-151. PubMed ID: 29444509
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial.
Roberts MA; Huang L; Lee D; MacGinley R; Troster SM; Kent AB; Bansal SS; Macdougall IC; McMahon LP
BMC Nephrol; 2016 Nov; 17(1):177. PubMed ID: 27852236
[TBL] [Abstract][Full Text] [Related]
17. The influence of renal function on vitamin D metabolism in the very elderly.
Van Pottelbergh G; Matheï C; Vaes B; Adriaensen W; Gruson D; Degryse JM
J Nutr Health Aging; 2013 Feb; 17(2):107-11. PubMed ID: 23364486
[TBL] [Abstract][Full Text] [Related]
18. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
[TBL] [Abstract][Full Text] [Related]
19. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
Kendrick J; Andrews E; You Z; Moreau K; Nowak KL; Farmer-Bailey H; Seals DR; Chonchol M
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1438-1446. PubMed ID: 28784657
[TBL] [Abstract][Full Text] [Related]
20. Short-Term Effects of Cholecalciferol Supplementation on cFGF23 Levels in Children with Chronic Kidney Disease and Vitamin D Insufficiency.
Sheriff A; Mathew G; Sinha A; Hari S; Gupta N; Ramakrishnan L; Hari P; Bagga A
Indian J Pediatr; 2022 Oct; 89(10):1037-1039. PubMed ID: 35771347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
